Tumor-immune evasion and resistance to PD-(L)1 inhibitors can also be mediated by canonical cancer signaling pathways such as Wnt–β-catenin signaling, cell cycle regulatory signaling, and mitogen-activated protein kinase signaling. Here, CD274 is linked to neoplasm.